As a member of the biotherapeutics group, the incumbent will play a key role in supporting the group's discovery and preclinical development efforts by utilizing skills and experience in chemical synthesis and purification/characterization. The incumbent will be responsible as a vital role in this mission through discovering and advancing novel ADC linker/payload technologies for targeted cancer therapies. The ideal candidate will have excellent skills and hands-on experience in conducting multi-step syntheses for novel ADC payloads, drug linkers, and key intermediates, possessing high motivation to perform bioconjugation. Experience in bioconjugation and/or bioconjugate analyses such as HPLC or Q-TOF MS is a plus.